First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

$ 12.00

4.5
(606)
In stock
Description

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Profile comparison between WATCHMAN 2.5 (A) and WATCHMAN FLX (B).

TCT DAIC

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Left Atrial Appendage (LAA) Occluders

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Frontiers A newly designed disk-lobe occluder with isogenous barbs for left atrial appendage closure: Initial multicenter experience

Baptist Health's Miami Cardiac & Vascular Institute Implants Newly Approved Left Atrial Appendage Closure Device for Patients with Non-valvular Atrial Fibrillation - Baptist Health South Florida

Meta-Analysis of WATCHMAN FLX™ Device vs Amplatzer™ Amulet™ Occluder

Left Atrial Appendage (LAA) Occluders